Home
Guidelines
Pathogens
Antimicrobials
PPSV‐23⁽²⁾ x single dose
Age ≥65
LTC residence
Alcoholism
Smoking
Homelessness
IDU
Asthma
COPD
Chronic CSF leak
Cochlear implant
Risk of aspiration
Cystic fibrosis
Diabetes
Chronic kidney disease
Chronic liver disease
History of pneumonia
Patients with chronic kidney disease and chronic liver disease should receive PPSV‐23⁽²⁾ booster x 1 ≥5 years after initial vaccination
All other patients do not require a booster vaccination
(1) Live attenuated vaccine (2) Inactive or component vaccine (3)
Only covered by MSP for certain indications
PPSV‐23: 23 valent pneumococcal polysaccharide vaccine PCV‐13: 13 valent pneumococcal conjugate vaccine